Filing Details
- Accession Number:
- 0001493152-21-006546
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-22 17:17:49
- Reporting Period:
- 2021-03-19
- Accepted Time:
- 2021-03-22 17:17:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1642380 | Oncocyte Corp | OCX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1299153 | Asbury Ronald Andrews | 15 Cushing Irvine CA 92618 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Acquisiton | 2021-03-19 | 11,000 | $4.79 | 113,698 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares were purchased at various prices ranging from $4.76 to $4.81.
Billionaire Hedge Funds
